[{"address1": "505 Coast Boulevard South", "address2": "Suite 307", "city": "La Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "858-952-5500", "website": "https://www.calcimedica.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated (CRAC) channel inhibitors, which is in phase 2 clinical trials for the treatment of acute pancreatitis, asparaginase induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops CM6336, an oral CRAC channel inhibitors for chronic inflammatory indications; and Auxora, for the treatment of acute ulcerative colitis and allergic asthma. The company is based in La Jolla, California.", "fullTimeEmployees": 13, "auditRisk": 10, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 2, "previousClose": 5.2, "open": 5.17, "dayLow": 5.17, "dayHigh": 5.4, "regularMarketPreviousClose": 5.2, "regularMarketOpen": 5.17, "regularMarketDayLow": 5.17, "regularMarketDayHigh": 5.4, "trailingPE": 0.33903676, "forwardPE": -3.128655, "volume": 21854, "regularMarketVolume": 21854, "averageVolume": 17345, "averageVolume10days": 11950, "averageDailyVolume10Day": 11950, "marketCap": 57507684, "fiftyTwoWeekLow": 1.75, "fiftyTwoWeekHigh": 8.38, "fiftyDayAverage": 5.21334, "twoHundredDayAverage": 4.04066, "currency": "USD", "enterpriseValue": 31797498, "floatShares": 4556314, "sharesOutstanding": 10749100, "sharesShort": 30201, "sharesShortPriorMonth": 33607, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0028, "heldPercentInsiders": 0.1467, "heldPercentInstitutions": 0.59642, "shortRatio": 2.03, "shortPercentOfFloat": 0.0052, "impliedSharesOutstanding": 10749100, "bookValue": 1.606, "priceToBook": 3.3312578, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -14939000, "trailingEps": 15.78, "forwardEps": -1.71, "enterpriseToEbitda": -1.483, "52WeekChange": 0.5927359, "SandP52WeekChange": 0.26238096, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CALC", "underlyingSymbol": "CALC", "shortName": "CalciMedica, Inc.", "longName": "CalciMedica, Inc.", "firstTradeDateEpochUtc": 1686749400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "1dade7b1-4e24-37e4-9b8f-e0dde73c0e11", "messageBoardId": "finmb_34235142", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.35, "targetHighPrice": 22.0, "targetLowPrice": 10.75, "targetMeanPrice": 16.69, "targetMedianPrice": 17.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 25710000, "totalCashPerShare": 2.392, "ebitda": -21442000, "quickRatio": 5.997, "currentRatio": 6.206, "returnOnAssets": -0.43488997, "returnOnEquity": -0.76091003, "freeCashflow": -10437750, "operatingCashflow": -25090000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]